Leah R. Neufeld - 17 Oct 2022 Form 3 Insider Report for Immuneering Corp (IMRX)

Role
Chief People Officer
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Leah Neufeld
Issuer symbol
IMRX
Transactions as of
17 Oct 2022
Net transactions value
$0
Form type
3
Filing time
20 Oct 2022, 08:10:45 UTC
Next filing
02 Nov 2022
SEC
View on sec.gov

No securities are beneficially owned.